Asensus Surgical, Inc. (ASXC)

Market Cap	94.92M
Revenue (ttm)	9.85M
Net Income (ttm)	-83.80M
Shares Out	272.84M
EPS (ttm)	-0.32
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	3,942,270
Open	0.3500
Previous Close	0.3500
Day's Range	0.3500 - 0.3500
52-Week Range	0.1700 - 0.4000
Beta	1.38
Analysts	Hold
Price Target	0.35 (0.0%)
Earnings Date	Aug 13, 2024

About ASXC

Asensus Surgical, Inc., a medical device company, engages in the research, development, and sale of medical device robotics to enhance minimally invasive surgery (MIS) in the United States, Europe, the Middle East, Africa, and Asia. It digitizes the interface between the surgeon and the patient to perform performance-guided surgery for surgeons to deliver outcomes to patients. The company’s products include Senhance System, a multi-port robotic surgery system that allows up to four arms to control robotic instruments and a camera for laparoscop...

• Industry: Medical Devices
• Sector: Healthcare
• Founded: 2006
• Employees: 209
• Stock Exchange: NYSEAMERICAN
• Ticker Symbol: ASXC
• Website: https://www.asensus.com

Financial Performance

In 2023, ASXC's revenue was $8.58 million, an increase of 21.02% compared to the previous year's $7.09 million. Losses were -$78.43 million, 3.80% more than in 2022.

Analyst Summary

According to 2 analysts, the average rating for ASXC stock is "Hold." The 12-month stock price target is $0.35, which is no change of 0.00% from the latest price.

Price Target

$0.35

Analyst Consensus: Hold